What is the equity of GC Cell this year?
GC Cell has equity of 534.02 B KRW this year.
In 2024, GC Cell's equity was 534.02 B KRW, a -0.82% increase from the 538.46 B KRW equity in the previous year.
GC Cell's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding GC Cell's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating GC Cell's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
GC Cell's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in GC Cell’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
GC Cell has equity of 534.02 B KRW this year.
The equity of GC Cell has increased/decreased by -0.82% decreased compared to the previous year.
A high equity is advantageous for investors of GC Cell as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of GC Cell, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of GC Cell can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of GC Cell can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of GC Cell include profits, dividend payments, capital increases, and acquisitions.
The equity of GC Cell is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, GC Cell can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, GC Cell paid a dividend of 100 KRW . This corresponds to a dividend yield of about 0.28 %. For the coming 12 months, GC Cell is expected to pay a dividend of 100 KRW.
The current dividend yield of GC Cell is 0.28 %.
GC Cell pays a quarterly dividend. This is distributed in the months of January, January, January, January.
GC Cell paid dividends every year for the past 3 years.
For the upcoming 12 months, dividends amounting to 100 KRW are expected. This corresponds to a dividend yield of 0.28 %.
GC Cell is assigned to the 'Health' sector.
To receive the latest dividend of GC Cell from 5/1/2024 amounting to 100 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.
The last dividend was paid out on 5/1/2024.
In the year 2023, GC Cell distributed 350 KRW as dividends.
The dividends of GC Cell are distributed in KRW.
Our stock analysis for GC Cell Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GC Cell Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.